Taking GLP-1s has been shown to reduce markers of inflammation
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity The New England Journal of Medicine (2025) 6
Kaye AD, Sala KR, Abbott BM, Dicke AN, Johnson LD, Wilson PA, Amarasinghe SN, Singh N, Ahmadzadeh S, Kaye AM, Shekoohi S, Varrassi G (2024) The Role of Glucagon-Like Peptide-1 Agonists in the Treatment of Multiple Sclerosis: A Narrative Review
While some research demonstrates that gut microbiota composition influences metabolic health, the translation to effective probiotic interventions is not straightforward
While gastrointestinal side effects like nausea and diarrhea are well-documented, some patients report flu-like symptoms during treatment
Skipping Meals Because GLP-1s reduce appetite, it may feel natural to skip meal, but this can lead to low energy, blood sugar drops, and overeating later